Autism and depression: Study shows why ‘gold standard treatment’ sometimes fails

| January 15, 2019
Image credit: CC0 Public Domain
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Cognitive behavioral therapy (CBT) is considered the gold standard treatment for depression. In fact, it is the gold standard treatment of the entire psychotherapy field due to its standing as the most researched and empirically supported form of therapy. For one group of people, however, the therapy does not always work and can lead to a worsening of symptoms. New research has found that those on the autism spectrum are less likely than their neurotypical counterparts to respond to the treatment for depression.

Though the failure of CBT to relieve depression symptoms in many of those with autism spectrum disorder has been detected by some therapists and counselors, research is beginning to provide explanations for these clinical findings. Interestingly, a diagnosis of autism spectrum disorder (ASD) was not required for researchers at Karolinska Institutet in Sweden to detect a link between autism and CBT failure, since the study looked at genetic risk scores for autism. A genetic risk score indicates how many genetic variants a person has for a particular illness or condition. The higher the autism genetic risk score, the less the symptoms of depression decreased — the authors concluded in a paper published in Molecular Psychiatry in November.

Depression is common in those with autism, a developmental disorder that ranges greatly in severity and symptom presentation. Experts do not yet agree on whether depression in ASD is a result of social rejection or physiological abnormalities (such as increased inflammation) found in those with autism. Most likely, depression arises as a consequence of both, along with many additional factors unique to each individual on the spectrum.

Alicia Raimundo, 29, a youth mental health consultant who is on the autism spectrum, told Genetic Literacy Project that she tried CBT repeatedly, but found that it was harmful due to differences in her “autism brain.” Raimundo pursued therapy for depression, anxiety, and some suicidal thoughts, and CBT was the therapists’ tool of choice. “When I did my first bout of CBT it was mostly just frustrating,” Raimundo said. “I knew that all my thoughts were wrong and that other thoughts were valid, but I couldn’t stop the thoughts. It all seemed obvious to me, but it didn’t work.” Though she wanted to stop CBT after her initial experience, she found that therapists forced it on her:

It just frustrated me and made my mental health worse because it felt like even though I was asking for help, I was not getting it and no one was listening to me.

Simone Sobel, an Atlanta-based clinical social worker and psychotherapist, uses CBT extensively in her private practice, including in her work with those on the autism spectrum. “I have found CBT to generally work well with folks on the autistic spectrum, particularly at the higher functioning end, such as those with Asperger syndrome,” Sobel told Genetic Literacy Project. “When it hasn’t worked for my autistic clients, it’s usually because they require an even more concrete, skills-based approach” than what CBT can provide. CBT requires working with thoughts and feelings, which can be too abstract or irrelevant to those with more moderate or severe forms of autism spectrum disorder, Sobel said:

One other reason I’ve found CBT to be ineffective with autistic individuals is because they have experienced significant trauma, usually from bullying and/or lack of understanding from family members that leads to harsh treatment. In this case, a cognitive approach may not be sufficient to treat the underlying trauma symptoms, and I use a brain-based processing approach, such as EMDR that can work very well for getting below the surface of the problem.

Sobel’s clinical observations align with the findings of the Karolinska Institutet’s research team, led by Christian Rück, psychiatrist and senior lecturer in the Department of Clinical Neuroscience. In the study, 894 participants who were diagnosed with depression completed a 12-week online CBT course (iCBT), and their symptom severity was tracked with the Montgomery-Åsberg Depression Rating Scale self report. The online CBT — which has been shown to be just as effective as traditional face-to-face CBT — was therapist-guided and presented as a series of modules with homework assignments.

Related article:  Viewpoint: Coronavirus journal—Anatomy of a pandemic
Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

DNA was collected from participants’ blood samples to find out how outcomes of CBT correlated with genetic variation. The participants’ genomes were compared to results from genome-wide association studies published in Psychiatric Genomics Consortium and from GWAS meta-analyses, to look for known variants associated with ASD, depression, bipolar disorder, ADHD, IQ and educational attainment.

Once all participants had completed the course, the results showed patients’ depression scores decreased during treatment, with the most improvement happening during the first few weeks. But “the higher the ASD genetic load, the less iCBT treatment response over time,” the researchers said. Patients with the highest ASD genetic risk scores had a poorer response to treatment than those with average or low ASD genetic risk scores.

The study was the first of its kind to show how genetic risk scores are associated with CBT treatment outcome. “Understanding how genetic variation affects the outcome of psychological treatment can help us understand why some people don’t respond to it,” said Rück. “Ultimately this can lead to improved treatment options.” The study of genetic predictors of psychological treatment is called therapygenetics, and is a relatively new field.

The researchers involved in the Karolinska Institutet study are clear that their results are preliminary. Replication is required to strengthen conclusions and detect robust and reliable associations between treatment response and autism genetic risk scores. Findings may show that CBT may not be the gold standard treatment for treating depression in those with autism spectrum disorder. Or CBT could be modified to address the unique mental health needs of those on the autism spectrum.

Kristen Hovet covers genetics, medical innovations, and the intersection of sociology and culture. Follow her on her website or Twitter @kristenhovet

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
a a b b a f ac a

Video: Death by COVID: The projected grim toll in historical context

The latest statistics, as of July 10, show COVID-19-related deaths in U.S. are just under 1,000 per day nationally, which is ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
types of oak trees

Infographic: Power of evolution? How oak trees came to dominate North American forests

Over the course of some 56 million years, oaks, which all belong to the genus Quercus, evolved from a single undifferentiated ...
biotechnology worker x

Can GMOs rescue threatened plants and crops?

Some scientists and ecologists argue that humans are in the midst of an "extinction crisis" — the sixth wave of ...
food globe x

Are GMOs necessary to feed the world?

Experts estimate that agricultural production needs to roughly double in the coming decades. How can that be achieved? ...
eating gmo corn on the cob x

Are GMOs safe?

In 2015, 15 scientists and activists issued a statement, "No Scientific consensus on GMO safety," in the journal Environmental Sciences ...
Screen Shot at PM

Charles Benbrook: Agricultural economist and consultant for the organic industry and anti-biotechnology advocacy groups

Independent scientists rip Benbrook's co-authored commentary in New England Journal calling for reassessment of dangers of all GMO crops and herbicides ...
Screen Shot at PM

ETC Group: ‘Extreme’ biotechnology critic campaigns against synthetic biology and other forms of ‘extreme genetic engineering’

The ETC Group is an international environmental non-governmental organization (NGO) based in Canada whose stated purpose is to monitor "the impact of emerging technologies and ...
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend